Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
29.95
-0.41 (-1.33%)
At close: Mar 24, 2026, 4:00 PM EDT
30.35
+0.41 (1.35%)
After-hours: Mar 24, 2026, 7:31 PM EDT
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.52 billion as of March 24, 2026. Its market cap has increased by 4.55% in one year.
Market Cap
1.52B
Enterprise Value
1.09B
1-Year Change
4.55%
Ranking
Category
Stock Price
$29.95
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.52B, a decrease of -15.47%. That is a compound annual growth rate of -3.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2026 | 1.52B | -13.45% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.61B |
| Harmony Biosciences Holdings | 1.60B |
| Vericel | 1.59B |
| Novavax | 1.57B |
| Generate Biomedicines | 1.56B |
| Iovance Biotherapeutics | 1.52B |
| Intellia Therapeutics | 1.52B |
| Nurix Therapeutics | 1.48B |